FIELD: medicine.
SUBSTANCE: blood is sampled from the patient's inferior concha to produce serum a sample of which is examined for proliferation marker detection by regional dehydration in an analytic cell. If observing the amplified proliferation marker in the form of a parallel line cascade, the need for preventive corticosteroid therapy for min. two months is stated. If the attenuated proliferation marker is observed in the form of small areas of parallel dash-lines, the need for preventive therapy of corticosteroids within one month is stated. No proliferation marker observed provides the preparation to be withdrawn.
EFFECT: use of the method enables the reliable detection of the length of the preventive therapy of corticosteroids in the patients with polypous rhinosinusitis.
1 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PREDICTION METHOD OF POLYPOUS RHINOSINUSITIS RELAPSE RISK FOR PREVENTIVE THERAPY INDICATIONS | 2007 |
|
RU2338205C1 |
| METHOD FOR EVALUATING EFFICACY OF DRUG-INDUCED THERAPY OF POLYPOUS RHINOSINUSITIS | 2010 |
|
RU2428695C1 |
| METHOD FOR INDIVIDUAL TREATMENT OF PATIENTS WITH BRONCHIAL ASTHMA | 2014 |
|
RU2564927C1 |
| METHOD OF TREATING CHRONIC RHINOSINUSITIS | 2011 |
|
RU2469737C1 |
| METHOD OF COMPLEX TREATMENT OF POLYPOUS RHINOSINUSITIS IN PATIENTS WITH BRONCHIAL ASTHMA | 2006 |
|
RU2324511C1 |
| METHOD FOR EVALUATING TREATMENT EFFICIENCY AND PREDICTING RECURRENCE OF CHRONIC POLYPOUS PURULENT PARANASAL SINUSITES | 2001 |
|
RU2191389C1 |
| METHOD OF CLINICAL EFFECTIVENESS IN PATIENTS WITH CHRONIC CONDITIONS OF NOSE AND ACCESSORY SINUSES OF NOSE | 2010 |
|
RU2431834C1 |
| METHOD OF EVALUATING SAFETY OF USE OF SYSTEMIC CORTICOSTEROIDS | 2014 |
|
RU2578972C1 |
| METHOD FOR PHENOTYPE DETERMINATION OF CHRONIC INFLAMMATORY DISEASES OF NOSE AND PARANASAL SINUSES IN CASE OF INDICATIONS FOR TARGETED THERAPY | 2023 |
|
RU2826780C1 |
| METHOD FOR PREDICTION OF EFFICIENCY OF SURGICAL TREATMENT OF CHILDREN WITH CHRONIC RHINOSINUSITIS | 2023 |
|
RU2817091C1 |
